Advise Saving Evenity for High-Risk Women With Osteoporosis

Evenity (ee-VEN-ih-tee, romosozumab) is the first med to increase bone growth AND decrease bone breakdown for postmenopausal osteoporosis.

Other osteoporosis meds do one or the other. For example, Forteo (teriparatide) and Tymlos (abaloparatide) build bone. Bisphosphonates (alendronate, etc) and Prolia (denosumab) slow bone breakdown.

Evenity is the first "sclerostin inhibitor." It's an injectable monoclonal antibody that blocks this protein involved in bone metabolism.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote